Sonoma pharmaceuticals launches new urinary tract infection product through distributors in new zealand, australia and south africa

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, and dermatological conditions, today announced that it has launched microdox®, an urinary tract infection catheter and bladder rinse in new zealand, australia and south africa. microdox® is a super-oxidized solu
SNOA Ratings Summary
SNOA Quant Ranking